Elektrofi is a platform technology company developing novel, multi-scale biomaterials for soft-tissue and medical filtration applications
Elektrofi’s biomaterials are precisely engineered from micro- and nano-scale fibers using a proprietary manufacturing platform that is compatible with a variety of biological and synthetic polymers. Our processing techniques are fully compatible with the inclusion of a range of functional agents and enable customization of the bioactivity for application-specific needs.
Elektrofi’s technology is advancing the state-of-the-art in biomaterials as a result of several unique attributes. These include:
SOFT FIBER SYNTHESIS
characteristics that preserve protein integrity;
with a number of different functionalization methods;
HIGH FIDELITY FIBER DEPOSITION
and direct-write capabilities;
A BENCHTOP FOOTPRINT
A manageable size for use in a variety of spaces
with a spectrum of fiber diameters from roughly 10 nm to greater than 1 μm;
HIGH PROCESSING RATES
two orders of magnitude higher than commercial methods.
Fibrous scaffolds exhibit biomimetic properties that encourage the ingrowth, attachment, and proliferation of various cells. This has made them good candidates for tissue regeneration applications such as external wound repair, where simple scaffolds have
been shown to dramatically expedite the healing process. In certain instances, for example, scaffold-assisted wound closure is more than 2 times faster than existing treatments.
Elektrofi’s multi-disciplinary team of scientists, engineers, and business professionals are working in a highly collaborative environment to address important clinical needs through the development of new materials
and manufacturing methods. Contact us at email@example.com to discuss job opportunities and submit your resume.